Corrigendum to “Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: Molecular docking, dynamics, & STRING protein-protein network analysis” [Inform Med Unlocked 41 (2023) 101323]

• Mahmoud Elkazzaz,
• Mahmoud Abdalrahman,
• Shahid Ullah,
• Israa M. Shamkh,
• Amr Ahmed,
• Ted X. Wu,
• Maii S. Elsharayidi,
• Mohammad Shahbaz Khan,
• Aziz-ur Rehman,
• Marwa M. Lotfy,
• Abdullah Haikal,
• Tianshun Gao

Affiliations

Mahmoud Elkazzaz

Department of Chemistry and Biochemistry, Faculty of Science, Damietta University, Damietta, 7952567, Egypt

Mahmoud Abdalrahman

Science Department, Milton Academy, Milton, MA, 02186, USA; Lowell Institute, CPS, Northeastern University, 360 Huntington Ave, Boston, MA, 02115, USA; Corresponding author. Science Department, Milton Academy, Milton, MA, 02186, USA.

Shahid Ullah

S Khan Lab, Mardan, Khyber Pakhtunkhwa, Pakistan

Israa M. Shamkh

Chemo and Bioinformatics Lab, Bio Search Research Institution, BSRI, Giza, 12613, Egypt

Amr Ahmed

Public Health Department, First Health Cluster, Ministry of Health, Riyadh, 966-11, Saudi Arabia

Ted X. Wu

Science Department, Milton Academy, Milton, MA, 02186, USA

Maii S. Elsharayidi

Central Public Health Laboratories, Egyptian Ministry of Health, Egypt

Mohammad Shahbaz Khan

Children's National Hospital, Washington, DC, USA

Aziz-ur Rehman

Keystone Pharmacogenomics LLC, Bensalem, PA, 19020, USA

Marwa M. Lotfy

Faculty of Pharmacy, Zagazig University, Zagazig, 44511, Egypt

Abdullah Haikal

Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt

Tianshun Gao

Big Data Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518107, PR China; Corresponding author.